Suppr超能文献

基于免疫信息学设计含细胞毒性T淋巴细胞相关抗原4细胞外结构域的多表位疫苗以对抗幽门螺杆菌。

Immmunoinformatics-based design of a multi-epitope vaccine with CTLA-4 extracellular domain to combat Helicobacter pylori.

作者信息

Ru Zhenyu, Yu Mingkai, Zhu Yuejie, Chen Zhiqiang, Zhang Fengbo, Zhang Zhiqiang, Ding Jianbing

机构信息

Department of Gastroenterology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

Department of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.

出版信息

FASEB J. 2022 Apr;36(4):e22252. doi: 10.1096/fj.202101538RR.

Abstract

In view of the high infection rate of Helicobacter pylori, a safe and effective vaccine is urgently needed. Recent trends in vaccine design have shifted toward safe and specific epitope-based vaccines. In this study, by using different immunoinformatics approaches, a total of eight linear B cell epitopes, four HTL and three CTL epitopes of FlaA and UreB proteins of H. pylori G27 strain were screened out, we also predicted the conformational epitopes of the two proteins. Then, the dominant epitopes were sequentially linked by appropriate linkers, and the cytotoxic T lymphocyte-associated antigen 4 extracellular domain was attached to the N-terminal of the epitope sequence. Meanwhile, molecular docking, molecular dynamics simulations and principal component analysis were performed to show that the multi-epitope vaccine structure had strong interactions with B7 (B7-1, B7-2) and Toll-like receptors (TLR-2, -4). Eventually, the effectiveness of the vaccine was validated using in silico cloning. These analyses suggested that the designed vaccine could target antigen-presenting cells and had high potency against H. pylori, which could provide a reference for the future development of efficient H. pylori vaccines.

摘要

鉴于幽门螺杆菌的高感染率,迫切需要一种安全有效的疫苗。疫苗设计的最新趋势已转向基于安全且特异表位的疫苗。在本研究中,通过使用不同的免疫信息学方法,共筛选出幽门螺杆菌G27菌株FlaA和UreB蛋白的8个线性B细胞表位、4个HTL表位和3个CTL表位,我们还预测了这两种蛋白的构象表位。然后,通过合适的接头将优势表位依次连接,并将细胞毒性T淋巴细胞相关抗原4胞外域连接到表位序列的N端。同时,进行分子对接、分子动力学模拟和主成分分析,以表明多表位疫苗结构与B7(B7-1、B7-2)和Toll样受体(TLR-2、-4)有强烈相互作用。最终,通过电子克隆验证了疫苗的有效性。这些分析表明,设计的疫苗可以靶向抗原呈递细胞,对幽门螺杆菌具有高效力,可为未来高效幽门螺杆菌疫苗的开发提供参考。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验